Abacus Life (NASDAQ:ABL – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.03, Zacks reports. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%. The business had revenue of $33.21 million during the quarter, compared to analysts’ expectations of $28.76 million.
Abacus Life Stock Up 6.6 %
Shares of NASDAQ ABL opened at $7.62 on Friday. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.29 and a quick ratio of 1.29. The company has a 50-day moving average price of $7.62 and a 200-day moving average price of $8.30. The stock has a market capitalization of $736.43 million, a P/E ratio of -42.33 and a beta of 0.14. Abacus Life has a 1 year low of $6.75 and a 1 year high of $12.50.
Analyst Ratings Changes
Separately, B. Riley reduced their target price on Abacus Life from $17.00 to $15.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Five equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $14.30.
About Abacus Life
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
See Also
- Five stocks we like better than Abacus Life
- The 3 Best Retail Stocks to Shop for in August
- MarketBeat Week in Review – 03/24 – 03/28
- When to Sell a Stock for Profit or Loss
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Does a Stock Split Mean?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.